WallStreetZenWallStreetZen

NASDAQ: CLGN
Collplant Biotechnologies Ltd Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CLGN past revenue growth

How has CLGN's revenue growth performed historically?
Company
1,752.92%
Industry
101.87%
Market
13.74%
CLGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CLGN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CLGN's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CLGN earnings and revenue history

Current Revenue
$10.8M
Current Earnings
-$6.7M
Current Profit Margin
-62.4%

CLGN Return on Equity

Current Company
-20.1%
Current Industry
1.4%
Current Market
22.1%
CLGN's Return on Equity (-20.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CLGN announces earnings.

CLGN Return on Assets

Current Company
-17.3%
Current Industry
-1.3%
CLGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CLGN Return on Capital Employed

Current Company
-16.85%
Current Industry
12.1%
CLGN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CLGN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CLGN$10.78M-$5.42M-$6.73M+70.70%N/A
TLSA$0.00-$15.34M-$15.40MN/AN/A
FIXX$2.76M-$129.62M-$131.91M+1.80%N/A
KNTE$0.00-$126.38M-$127.16MN/AN/A
AVRO$0.00-$381.00k-$5.48MN/AN/A
View Top Biotech Stocks

Collplant Biotechnologies Earnings & Revenue FAQ

What were CLGN's earnings last quarter?

On Invalid Date, Collplant Biotechnologies (NASDAQ: CLGN) reported Q2 2023 earnings per share (EPS) of $0.51, up 230.77% year over year. Total Collplant Biotechnologies earnings for the quarter were $5.76 million. In the same quarter last year, Collplant Biotechnologies's earnings per share (EPS) was -$0.39.

If you're new to stock investing, here's how to buy Collplant Biotechnologies stock.

What was CLGN's earnings growth in the past year?

As of Q3 2023, Collplant Biotechnologies's earnings has grown year over year. Collplant Biotechnologies's earnings in the past year totalled -$6.73 million.

What was CLGN's revenue last quarter?

On Invalid Date, Collplant Biotechnologies (NASDAQ: CLGN) reported Q2 2023 revenue of $10.18 million up 15,330.3% year over year. In the same quarter last year, Collplant Biotechnologies's revenue was $66.00 thousand.

What was CLGN's revenue growth in the past year?

As of Q3 2023, Collplant Biotechnologies's revenue has grown 1,752.92% year over year. This is 1,651.05 percentage points higher than the US Biotechnology industry revenue growth rate of 101.87%. Collplant Biotechnologies's revenue in the past year totalled $10.78 million.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.